Myocarditis: Current Trends in Diagnosis and Treatment

@article{Magnani2006MyocarditisCT,
  title={Myocarditis: Current Trends in Diagnosis and Treatment},
  author={Jared W. Magnani and G. William Dec},
  journal={Circulation},
  year={2006},
  volume={113},
  pages={876-890}
}
Myocarditis is clinically and pathologically defined as “inflammation of the myocardium.” Despite its rather clear-cut definition, the classification, diagnosis, and treatment of myocarditis continue to prompt considerable debate. The more routine use of endomyocardial biopsy has helped to better define the natural history of human myocarditis and to clarify clinicopathological correlations. Clinical presentations of the disease range from nonspecific systemic symptoms (fever, myalgias… Expand
Epidemiology and Prognosis of Myocarditis and dilated Cardiomyopathy: Predictive Value of Clinical Parameters and Biopsy Findings
TLDR
Although endomyocardial biopsy remains the “gold standard” for establishing the diagnosis, cardiac magnetic resonance imaging with gadolinium enhancement has rapidly emerged as the screening procedure of choice. Expand
Current Diagnosis and Management of Myocarditis
TLDR
Patients who can be managed by conventional therapy or who require specific treatment based on underlying etiology, such as antiviral or intravenous immunoglobulin infusion are directed to endomyocardial biopsy. Expand
Viral myocarditis—diagnosis, treatment options, and current controversies
TLDR
This Review explores the pathophysiology, natural history, and modes of diagnosis of myocarditis, as well as evidence-based treatment strategies, and indicates the landscape of therapies for this elusive disease is poised to improve. Expand
The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature
TLDR
There is no consensus regarding aetiology, clinical presentation, diagnosis, and management of myocarditis in pediatric patients, and emerging evidence to support investigations such as serum N-terminal B-type natriuretic peptide levels, as well as cardiac magnetic resonance imaging as adjuncts to the clinical diagnosis. Expand
Myocarditis in Childhood: An Update on Etiology, Diagnosis and Management
TLDR
It has been shown that most common known cause of dilated cardiomyopathy is myocarditis (46%), and several mechanisms were postulated for progression of myocardococcal inflammation to dilated heart failure and sudden death, including direct viral injury. Expand
Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
TLDR
The aim of this review is to approach the recently discovered facets of paediatric myocarditis regarding its progression to dilated cardiomyopathy. Expand
Republished: Pathogenesis and diagnosis of myocarditis
TLDR
Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests. Expand
Acute myocarditis and sudden death in the young: Case report
TLDR
The case of a young girl dying suddenly due to acute lymphocytic myocarditis is presented, and the characterization of the virus trough Polimerase Chain Reaction is recommended. Expand
Pathogenesis and diagnosis of myocarditis
TLDR
Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests. Expand
Clinical presentation of myocarditis in pediatric: the role of cardiac magnetic resonance in diagnosis
TLDR
This case shows how CMR is important and highly accurate in diagnosing myocarditis through a case whereby a boy had complaints of chest pain and his CMR examination showed normal cardiac morphology with normal function of right and left ventricular, but with myocardial edema and tissue fibrosis, which confirmed the diagnosis ofMyocarditis according to the Lake Louise Consensus criteria. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 159 REFERENCES
Introduction to Clinical Myocarditis
TLDR
The more routine use of endomyocardial biopsy has helped better define the natural history of human myocarditis and clarify clinicopathologic correlations. Expand
Clinicopathoiogic description of myocarditis
TLDR
A new clinicopathologic classification of myocarditis is identified in which four distinct subgroups are identified, characterized by a persistent histologic infiltrate, often with foci of myocyte necrosis but without ventricular dysfunction despite other cardiovascular symptoms such as chest pain or palpitation. Expand
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.
TLDR
Fulminant myocarditis is a distinct clinical entity with an excellent long-term prognosis and Aggressive hemodynamic support is warranted for patients with this condition. Expand
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome.
TLDR
It is concluded that many cases of unexplained dilated cardiomyopathy result from myocarditis, and the efficacy of immunosuppressive treatment must still be established. Expand
Predictors of Disease Course in Patients With Acute Myocarditis
TLDR
Serum levels of soluble Fas and soluble Fas ligand levels at initial presentation appear to be a good serological marker to predict the prognosis of acute myocarditis. Expand
Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?
TLDR
Patients with heart failure due to IDC should be treated with conventional heart failure regimens, including diuretics, angiotensin-converting enzyme (ACE) inhibitors, digitalis, β-blockers, vasodilators, aldosterone antagonists, and other effective medications and technology. Expand
Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology
TLDR
Contrast enhancement is a frequent finding in the clinical setting of suspected myocarditis and is associated with active inflammation defined by histopathology and is a valuable tool for the evaluation and monitoring of inflammatory heart disease. Expand
Giant Cell Myocarditis: Diagnosis and Treatment
TLDR
A randomized trial of immunosuppression including muromonab-CD3, cyclosporine, and steroids is underway to confirm and extend data from a Lewis rat model and from observational human studies suggest that giant cell myocarditis is mediated by T lymphocytes and may respond to treatment aimed at attenuating T cell function. Expand
Advances in the understanding of myocarditis.
TLDR
The objective of this article is to better define myocarditis for both clinicians and clinical scientists by setting it in the framework of 3 phases of disease, in which the viral stage is reviewed, the autoimmune phase is examined and the remodeling processes are considered. Expand
From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.
TLDR
The rather discouraging results obtained to date with immunosuppressive agents in the treatment of viral myocarditis indicated the importance of sparing neutralizing antibody production, which may be controlled by B cells, and raised the possibility of promising developments in immunomodulating therapy. Expand
...
1
2
3
4
5
...